BOSTON, MA – Diversified Healthcare Trust has sold an additional 10% equity interest in a life science complex in Boston's Seaport district to an existing joint-venture partner for $108 million.
The class A, two-building complex features 1.1 million rentable square feet of lab, office and street-level retail space. Located at 11 Fan Pier and 50 Northern Ave., the two 15-story properties are LEED Gold certified and are 95% leased to Vertex Pharmaceuticals Inc.
The purchase partner now owns a 45% interest in the joint-venture. DHC owns 10% equity interest and another partner owns the remaining 45% equity interest.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Ingrid Tunberg
Ingrid Tunberg sits on the editorial team as a coordinator and reporter for Real Estate Forum and GlobeSt.com. She is responsible for writing stories, assisting with industry awards and marketing nomination events. Previously, Ingrid worked as a copywriter across various industries throughout New York City and Chicago.
